Accurately assessing pain in the pediatric population is one of the most complex tasks in clinical medicine. Unlike adults, children lack the cognitive and linguistic maturity to consistently translate their internal nociceptive experiences into a standardized numerical value. For the board-certified pain physician, mastering pediatric assessment requires a developmental approach, transitioning from the observation of physiological and behavioral cues in neonates to the use of self-report tools in adolescents.

1. The Neonatal and Infant Population (Ages 0–12 Months)

Assessment in this group is entirely dependent on observer-rated scales. It was historically (and incorrectly) believed that neonates did not feel pain due to incomplete myelination. We now know that the nociceptive pathways are functional by the second trimester, and neonates may actually experience increased sensitivity to pain due to a lack of mature inhibitory descending pathways.

Physiological Markers

In the acute setting, neonates exhibit “stress responses” to pain. While these are not specific to pain (they can also indicate hunger or cold), they provide a clinical baseline:

• Cardiovascular: Tachycardia and hypertension.
• Respiratory: Tachypnea, decreased oxygen saturation, and shallow breathing.
• Endocrine: Increases in cortisol, catecholamines, and glucagon.

Validated Behavioral Scales

• NIPS (Neonatal Infant Pain Scale): Evaluates facial expression, cry, breathing patterns, arms, legs, and state of arousal.
• CRIES Scale: Specifically designed for postoperative pain. It measures Crying, Requiring O2 for Sat > 95%, Increased vital signs, Expression, and Sleeplessness.
• FLACC Scale (Face, Legs, Activity, Cry, Consolability): Though used for older infants and toddlers, it is the “gold standard” for non-verbal behavioral assessment.

2. The Toddler and Preschool Years (Ages 1–5 Years)

As children enter the “pre-operational” stage of development, they begin to develop a vocabulary for pain, but they still struggle with the concept of intensity. A toddler may use words like “owie” or “boo-boo” but cannot distinguish between a “3” and an “8” on a scale.

The Challenge of Egocentrism

Children in this age group are egocentric and often believe that adults already know how they feel. They may also associate pain with punishment.

• Tool of Choice: The Wong-Baker FACES Pain Rating Scale. * Clinical Pearl: It is crucial to explain to the child that the faces represent how they feel inside, not what their face looks like. Children in this stage may “mask” their expressions to appear “brave” or avoid a feared intervention (like an injection).

3. School-Age Children (Ages 6–12 Years)

By age 7 or 8, most children have developed “concrete operational” thinking. They understand seriation (ordering things) and can begin to use more abstract scales.

• Visual Analog Scale (VAS) and Numerical Rating Scale (NRS): Most children older than 8 can successfully use an NRS (0–10).
• The OUCHER Scale: Similar to the FACES scale but uses photographs of children of different ethnic backgrounds to improve cultural validity and relatability.
• Localization: School-age children can accurately point to the site of pain and describe it using simple adjectives (stinging, aching, sharp).

4. Adolescents (Ages 13+ Years)

Adolescents have the cognitive capacity for “formal operational” thinking. They can describe the quality, temporal pattern, and psychosocial impact of their pain.

• Assessment Nuance: While they can use adult-style NRS and VAS scales, assessment in this group is often complicated by social factors. Adolescents may under-report pain to appear “tough” or over-report pain if there are underlying issues with school avoidance or depression.
• Multidimensional Tools: Tools like the Pediatric Pain Questionnaire (PPQ) or the Brief Pain Inventory (Modified for Pediatrics) are useful here, as they assess how pain interferes with sleep, mood, and social interaction.

5. Assessment in the Neurologically Impaired Child

Children with Cerebral Palsy (CP) or severe developmental delays represent a high-risk group for under-treated pain. Their baseline “normal” may include spasticity or grimacing, making standard FLACC scores difficult to interpret.

• Non-Communicating Children’s Pain Checklist (NCCPC): This is a specialized tool that relies on inputs from the primary caregiver (usually the parents), who are best attuned to the child’s subtle “pain behaviors,” such as increased muscle tone, changes in vocalization, or altered sleep-wake cycles.

6. The “Gold Standard” Principle

A recurring board concept is the hierarchy of pain assessment. Even in pediatrics, the self-report is the gold standard whenever possible.

1. Self-Report: (If the child is cognitively >4–5 years).
2. Behavioral Observation: (Using validated scales like FLACC).
3. Physiological Measures: (Heart rate, BP—least specific).
4. Parental/Caregiver Input: (Vital for children with special needs).

7. The Functional Assessment

In pain medicine, we focus less on the “number” and more about the “function.” A pediatric pain assessment is incomplete without evaluating the Global Functioning:

• School Attendance: Is the child missing school?
• Play: Is the child engaging with peers?
• Developmental Milestones: Has the chronic pain caused a regression in motor or social skills?

For the board exam, remember that “Chronic Pain” in pediatrics is often a diagnosis of the family unit, not just the child. Assessment must include an evaluation of parental catastrophizing, as high levels of parental anxiety are strongly correlated with higher pain scores and poorer functional outcomes in the child.

---

High-Yield “Board Pearls”

• Neonatal Opioid Half-life: Morphine clearance is significantly reduced in neonates due to immature glucuronidation (UGT2B7 enzyme).
• Faces vs. Numbers: Transition from FACES to NRS usually occurs between ages 7 and 8.
• The “Double Effect”: In pediatric palliative care, the intention to relieve pain is ethically paramount, even if the medication carries a risk of respiratory depression.
• FLACC: Specifically used for ages 2 months to 7 years, or older children who cannot communicate.